Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83dffc287358331deccd774ddf93f551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbffa3b81b3b862dc7220b5648f5f745 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 |
filingDate |
2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b929914a643e297af84e058a032e6c8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e75bbc8f3c69873b76eeecac476f57b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efac43ad57aa351ed9b5dc981b61a3ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bdceb3e3965b7dc713f57a7b9bb3ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451dc791a29b4231eb5ee7c5584667ae |
publicationDate |
2018-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180013738-A |
titleOfInvention |
Composition for preventing or treating erectile dysfunction, ischemic disease or peripheral neurological disorder comprising fusion protein comprising LRG1 protein |
abstract |
The present invention relates to a fusion protein comprising a LRG1 glycoprotein and a composition for preventing or treating erectile dysfunction, ischemic diseases or peripheral neuropathy comprising the same as an active ingredient. The LRG1 glycoprotein or LRG1-Fc fusion protein according to the present invention increases the level of endothelial cell and nerve cell specific protein to induce the regeneration of the corpus cavernosum endothelial cells and nerve cells and the erectile dysfunction improvement And may be useful for preventing or treating erectile dysfunction. In addition, the LRG1 glycoprotein or LRG1-Fc fusion protein according to the present invention has vascular and nerve regeneration effects, and thus can be usefully used for the prophylaxis or treatment of ischemic diseases or peripheral nerve diseases. |
priorityDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |